|
|
|
Volumn 69, Issue 179, 2004, Pages 55763-55765
|
|
Medicare program; manufacturer submission of manufacturer's average sales price (ASP) data for Medicare Part B drugs and biologicals. Final rule.
[No Author Info available]
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ARTICLE;
DRUG COST;
DRUG INDUSTRY;
DRUG LEGISLATION;
ECONOMICS;
HUMAN;
LEGAL ASPECT;
MEDICARE;
PHARMACOECONOMICS;
PROSPECTIVE PAYMENT;
UNITED STATES;
DRUG COSTS;
DRUG INDUSTRY;
ECONOMICS, PHARMACEUTICAL;
HUMANS;
LEGISLATION, DRUG;
MEDICARE PART B;
PROSPECTIVE PAYMENT SYSTEM;
UNITED STATES;
|
|
EID: 4644273478
PISSN: 00976326
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
|
Times cited : (1)
|
|
References (0)
|